Clinicopathological features of Bu Gu Zhi‐induced liver injury, a long‐term follow‐up cohort study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathological features of Bu Gu Zhi‐induced liver injury, a long‐term follow‐up cohort study
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 40, Issue 3, Pages 571-580
Publisher
Wiley
Online
2019-11-23
DOI
10.1111/liv.14306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Review of Published Data on Herb Induced Liver Injury
- (2019) Jung-Hwan Byeon et al. JOURNAL OF ETHNOPHARMACOLOGY
- Bakuchiol: A newly discovered warrior against organ damage
- (2019) Zhenlong Xin et al. PHARMACOLOGICAL RESEARCH
- Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
- (2019) Tao Shen et al. GASTROENTEROLOGY
- Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury
- (2018) Jia-bo Wang et al. Chinese Journal of Integrative Medicine
- Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry
- (2018) Inmaculada Medina-Caliz et al. Clinical Gastroenterology and Hepatology
- Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury
- (2018) Lili Pang et al. Clinics and Research in Hepatology and Gastroenterology
- A Study of NMR-Based Hepatic and Serum Metabolomics in a Liver Injury Sprague–Dawley Rat Model Induced by Psoralen
- (2018) Yue Zhang et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Chinese Herbal Medicine Hepatotoxicity: The Evaluation and Recognization Based on Large-scale Evidence Ddatabase
- (2018) Zhi Liu et al. CURRENT DRUG METABOLISM
- The Development of a Database for Herbal and Dietary Supplement Induced Liver Toxicity
- (2018) Jieqiang Zhu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinicopathological features of He Shou Wu- induced liver injury: This ancient anti-aging therapy is not liver-friendly
- (2018) Yan Wang et al. LIVER INTERNATIONAL
- Drug-induced Liver Injury
- (2017) David E. Kleiner GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- CSH guidelines for the diagnosis and treatment of drug-induced liver injury
- (2017) Yue-cheng Yu et al. Hepatology International
- Histopathological challenges in suspected drug-induced liver injury
- (2017) David E. Kleiner LIVER INTERNATIONAL
- Bakuchiol Contributes to the Hepatotoxicity of Psoralea corylifolia in Rats
- (2017) Zhi-Jian Li et al. PHYTOTHERAPY RESEARCH
- Liver injury from herbal and dietary supplements
- (2016) Victor J. Navarro et al. HEPATOLOGY
- The histopathological evaluation of drug-induced liver injury
- (2016) David E Kleiner HISTOPATHOLOGY
- Identification and characterization of naturally occurring inhibitors against UDP-glucuronosyltransferase 1A1 in Fructus Psoraleae (Bu-gu-zhi)
- (2015) Xin-Xin Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
- (2014) Naga P Chalasani et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Can Medical Herbs Stimulate Regeneration or Neuroprotection and Treat Neuropathic Pain in Chemotherapy-Induced Peripheral Neuropathy?
- (2013) Sven Schröder et al. Evidence-based Complementary and Alternative Medicine
- Clinical practice guideline of traditional medicine for primary osteoporosis
- (2011) Yan-ming Xie et al. Chinese Journal of Integrative Medicine
- Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
- (2011) G P Aithal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury
- (2011) Ayako Suzuki et al. HEPATOLOGY
- Liver injury associated with the use ofFructus Psoraleae(Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine
- (2009) Wing I Cheung et al. CLINICAL TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now